Pancreatic acinar cell carcinoma

A multi-institutional study

Jesus M. Matos, C. Schmidt, Olivier Turrini, Narasimhan P. Agaram, Marco Niedergethmann, Hans Detlev Saeger, Nipun Merchant, Cynthia S. Johnson, Keith D. Lillemoe, Robert Grützmann

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Introduction The presentation and outcome of patients with acinar cell carcinoma (ACC) of the pancreas compared to the more common ductal cell adenocarcinoma (DCA) may be distinct. This study combines the experience with ACC from multiple academic institutions to better understand its natural history and outcomes. Methods This study is a multi-institutional retrospective review of patients with ACC. Results Between 1988 and 2008, 17 patients were identified with pathologically confirmed ACC. Median age at presentation was 59 years. Common presenting symptoms were abdominal pain (60%), back pain (50%), and weight loss (45%). Fifteen patients underwent 16 operations: pancreaticoduodenectomy (nine), distal pancreatectomy (four), and exploratory laparotomy (three). Mean tumor size was 5.3 cm. American Joint Commission on Cancer tumor stages were stage I (two), stage II (eight), stage III (four), and stage IV (three). Overall, 1- and 5-year survival rates were 88% and 50%, respectively. In resected cases (13), 1- and 5-year survival rates were 92% and 53%, respectively. Median survival in resected cases was 61 months. This is in contrast to 1,608 patients with ductal cell adenocarcinoma who underwent resection identified from recent literature reports where the average median survival was only 24 months. There was no discernable difference in the outcomes of patients with ACC between United States and Germany patients. Conclusion Acinar cell carcinoma of the pancreas is rare and appears to have a presentation and outcome distinct from the more common pancreatic DCA. Based upon these data, the outcome of patients with ACC is superior to that of DCA.

Original languageEnglish
Pages (from-to)1495-1502
Number of pages8
JournalJournal of Gastrointestinal Surgery
Volume13
Issue number8
DOIs
StatePublished - Jul 2009

Fingerprint

Acinar Cell Carcinoma
Adenocarcinoma
Pancreas
Survival Rate
Neoplasms
Pancreatectomy
Pancreaticoduodenectomy
Survival
Pancreatic Carcinoma
Back Pain
Natural History
Laparotomy
Abdominal Pain
Germany
Weight Loss
Joints

Keywords

  • Acinar cell carcinoma
  • Multi-institutional
  • Pancreatectomy
  • Pancreatic cancer
  • Resection
  • Surgery

ASJC Scopus subject areas

  • Surgery
  • Gastroenterology

Cite this

Matos, J. M., Schmidt, C., Turrini, O., Agaram, N. P., Niedergethmann, M., Saeger, H. D., ... Grützmann, R. (2009). Pancreatic acinar cell carcinoma: A multi-institutional study. Journal of Gastrointestinal Surgery, 13(8), 1495-1502. https://doi.org/10.1007/s11605-009-0938-z

Pancreatic acinar cell carcinoma : A multi-institutional study. / Matos, Jesus M.; Schmidt, C.; Turrini, Olivier; Agaram, Narasimhan P.; Niedergethmann, Marco; Saeger, Hans Detlev; Merchant, Nipun; Johnson, Cynthia S.; Lillemoe, Keith D.; Grützmann, Robert.

In: Journal of Gastrointestinal Surgery, Vol. 13, No. 8, 07.2009, p. 1495-1502.

Research output: Contribution to journalArticle

Matos, JM, Schmidt, C, Turrini, O, Agaram, NP, Niedergethmann, M, Saeger, HD, Merchant, N, Johnson, CS, Lillemoe, KD & Grützmann, R 2009, 'Pancreatic acinar cell carcinoma: A multi-institutional study', Journal of Gastrointestinal Surgery, vol. 13, no. 8, pp. 1495-1502. https://doi.org/10.1007/s11605-009-0938-z
Matos, Jesus M. ; Schmidt, C. ; Turrini, Olivier ; Agaram, Narasimhan P. ; Niedergethmann, Marco ; Saeger, Hans Detlev ; Merchant, Nipun ; Johnson, Cynthia S. ; Lillemoe, Keith D. ; Grützmann, Robert. / Pancreatic acinar cell carcinoma : A multi-institutional study. In: Journal of Gastrointestinal Surgery. 2009 ; Vol. 13, No. 8. pp. 1495-1502.
@article{2fc14c1f0b324a01abb4d361c59e86a7,
title = "Pancreatic acinar cell carcinoma: A multi-institutional study",
abstract = "Introduction The presentation and outcome of patients with acinar cell carcinoma (ACC) of the pancreas compared to the more common ductal cell adenocarcinoma (DCA) may be distinct. This study combines the experience with ACC from multiple academic institutions to better understand its natural history and outcomes. Methods This study is a multi-institutional retrospective review of patients with ACC. Results Between 1988 and 2008, 17 patients were identified with pathologically confirmed ACC. Median age at presentation was 59 years. Common presenting symptoms were abdominal pain (60{\%}), back pain (50{\%}), and weight loss (45{\%}). Fifteen patients underwent 16 operations: pancreaticoduodenectomy (nine), distal pancreatectomy (four), and exploratory laparotomy (three). Mean tumor size was 5.3 cm. American Joint Commission on Cancer tumor stages were stage I (two), stage II (eight), stage III (four), and stage IV (three). Overall, 1- and 5-year survival rates were 88{\%} and 50{\%}, respectively. In resected cases (13), 1- and 5-year survival rates were 92{\%} and 53{\%}, respectively. Median survival in resected cases was 61 months. This is in contrast to 1,608 patients with ductal cell adenocarcinoma who underwent resection identified from recent literature reports where the average median survival was only 24 months. There was no discernable difference in the outcomes of patients with ACC between United States and Germany patients. Conclusion Acinar cell carcinoma of the pancreas is rare and appears to have a presentation and outcome distinct from the more common pancreatic DCA. Based upon these data, the outcome of patients with ACC is superior to that of DCA.",
keywords = "Acinar cell carcinoma, Multi-institutional, Pancreatectomy, Pancreatic cancer, Resection, Surgery",
author = "Matos, {Jesus M.} and C. Schmidt and Olivier Turrini and Agaram, {Narasimhan P.} and Marco Niedergethmann and Saeger, {Hans Detlev} and Nipun Merchant and Johnson, {Cynthia S.} and Lillemoe, {Keith D.} and Robert Gr{\"u}tzmann",
year = "2009",
month = "7",
doi = "10.1007/s11605-009-0938-z",
language = "English",
volume = "13",
pages = "1495--1502",
journal = "Journal of Gastrointestinal Surgery",
issn = "1091-255X",
publisher = "Springer New York",
number = "8",

}

TY - JOUR

T1 - Pancreatic acinar cell carcinoma

T2 - A multi-institutional study

AU - Matos, Jesus M.

AU - Schmidt, C.

AU - Turrini, Olivier

AU - Agaram, Narasimhan P.

AU - Niedergethmann, Marco

AU - Saeger, Hans Detlev

AU - Merchant, Nipun

AU - Johnson, Cynthia S.

AU - Lillemoe, Keith D.

AU - Grützmann, Robert

PY - 2009/7

Y1 - 2009/7

N2 - Introduction The presentation and outcome of patients with acinar cell carcinoma (ACC) of the pancreas compared to the more common ductal cell adenocarcinoma (DCA) may be distinct. This study combines the experience with ACC from multiple academic institutions to better understand its natural history and outcomes. Methods This study is a multi-institutional retrospective review of patients with ACC. Results Between 1988 and 2008, 17 patients were identified with pathologically confirmed ACC. Median age at presentation was 59 years. Common presenting symptoms were abdominal pain (60%), back pain (50%), and weight loss (45%). Fifteen patients underwent 16 operations: pancreaticoduodenectomy (nine), distal pancreatectomy (four), and exploratory laparotomy (three). Mean tumor size was 5.3 cm. American Joint Commission on Cancer tumor stages were stage I (two), stage II (eight), stage III (four), and stage IV (three). Overall, 1- and 5-year survival rates were 88% and 50%, respectively. In resected cases (13), 1- and 5-year survival rates were 92% and 53%, respectively. Median survival in resected cases was 61 months. This is in contrast to 1,608 patients with ductal cell adenocarcinoma who underwent resection identified from recent literature reports where the average median survival was only 24 months. There was no discernable difference in the outcomes of patients with ACC between United States and Germany patients. Conclusion Acinar cell carcinoma of the pancreas is rare and appears to have a presentation and outcome distinct from the more common pancreatic DCA. Based upon these data, the outcome of patients with ACC is superior to that of DCA.

AB - Introduction The presentation and outcome of patients with acinar cell carcinoma (ACC) of the pancreas compared to the more common ductal cell adenocarcinoma (DCA) may be distinct. This study combines the experience with ACC from multiple academic institutions to better understand its natural history and outcomes. Methods This study is a multi-institutional retrospective review of patients with ACC. Results Between 1988 and 2008, 17 patients were identified with pathologically confirmed ACC. Median age at presentation was 59 years. Common presenting symptoms were abdominal pain (60%), back pain (50%), and weight loss (45%). Fifteen patients underwent 16 operations: pancreaticoduodenectomy (nine), distal pancreatectomy (four), and exploratory laparotomy (three). Mean tumor size was 5.3 cm. American Joint Commission on Cancer tumor stages were stage I (two), stage II (eight), stage III (four), and stage IV (three). Overall, 1- and 5-year survival rates were 88% and 50%, respectively. In resected cases (13), 1- and 5-year survival rates were 92% and 53%, respectively. Median survival in resected cases was 61 months. This is in contrast to 1,608 patients with ductal cell adenocarcinoma who underwent resection identified from recent literature reports where the average median survival was only 24 months. There was no discernable difference in the outcomes of patients with ACC between United States and Germany patients. Conclusion Acinar cell carcinoma of the pancreas is rare and appears to have a presentation and outcome distinct from the more common pancreatic DCA. Based upon these data, the outcome of patients with ACC is superior to that of DCA.

KW - Acinar cell carcinoma

KW - Multi-institutional

KW - Pancreatectomy

KW - Pancreatic cancer

KW - Resection

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=70349485576&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349485576&partnerID=8YFLogxK

U2 - 10.1007/s11605-009-0938-z

DO - 10.1007/s11605-009-0938-z

M3 - Article

VL - 13

SP - 1495

EP - 1502

JO - Journal of Gastrointestinal Surgery

JF - Journal of Gastrointestinal Surgery

SN - 1091-255X

IS - 8

ER -